Reconstructive Urology And Tissue Engineering, Tuesday 4th September 2007 At The 29th Congress Of The Societe Internationale D'Urologie In Paris

Main Category: Urology / Nephrology
Also Included In: Conferences;  Medical Devices / Diagnostics
Article Date: 30 Aug 2007 - 1:00 PDT

email to a friend   printer friendly   opinions  

Cook Urology , a division of Cook Medical, the world's largest private medical device company, invites you to the Reconstructive Urology and Tissue Engineering Symposium at the 29th Congress of the Société Internationale d'Urologie in Paris.

Symposium panellists will discuss the latest technology for the treatment of Peyronie's Disease (penile curvature), nephron sparing partial nephrectomy and stress urinary incontinence.

The symposium is in room 252B at the Palais de Congrès, Paris. Press registration for the SIU Congress is required for admittance.

Agenda

16:30 - 16:35 Chairman's Welcome and Introduction
Dr. Hervé Baumert, MD - Paris Saint Joseph Hospital Trust, Department of Urology, Paris, France

16:35 - 16:55 Nephron Sparing Partial Nephrectomy with Surgisis® Biodesign™
Dr. Robert de Petriconi - Department of Urology, Ulm University Hospital, University of Ulm, Germany

17:00 - 17:20 Peyronie's Repair with Surgisis Biodesign
Dr. Gerald H. Jordan - Professor, Department of Urology, Eastern Virginia Medical School; and Director, Devine Centre for Genitourinary Reconstructive Surgery Sentara, Norfolk, Virginia, USA

17:25 - 17:45 Muscle Derived Cells and Tissue Engineering for SUI
Dr. Michael Chancellor - Professor of Urology and OBGYN, McGowan Institute of Regenerative Medicine, Pittsburgh, PA, USA
Recent coverage of Dr. Chancellor's research on: USA TODAY

17:50 - 18:00 Closing Comments and Discussion
Dr. Hervé Baumert, MD

About Surgisis® Biodesign™

The Surgisis® Biodesign™ material communicates with the patient's body, signalling surrounding tissue to grow across the graft's scaffold, allowing the body to restore itself. Because it remodels into vascularised tissue, Surgisis Biodesign allows the body's own defence mechanisms to respond to infections.

Unlike synthetic mesh and cross linked grafts, Surgisis Biodesign is undetectable once the healing process is complete. It provides a permanent repair without a permanent material. Over time, it remodels to become as strong as the patient's own tissue.

The aim of the Symposium is to explore the awareness and application of Surgisis Biodesign, using the very latest information on nephron sparing partial nephrectomy and Peyronie's repair and stress urinary incontinence.

About Cook Medical

Cook Medical was the first company to introduce interventional devices in the United States. Today, the company participates in all global markets, integrating device design, biopharma, gene and cell therapy and biotechnology to enhance patient safety and improve clinical outcomes. Cook won the prestigious Medical Device Manufacturer of the Year for 2006 from Medical Device and Diagnostic Industry magazine.

http://www.cookmedical.com

• Additional
• References
• Citations